Bejelentkezés Regisztrálj ingyen

Ayala Pharmaceuticals EV/Sales

Mi az Ayala Pharmaceuticals EV/Sales?

A EV/Sales az Ayala Pharmaceuticals Inc. - N/A

Mi a EV/Sales meghatározása?



Enterprise value to sales ratio compares a company’s total value to its sales.

ttm (trailing twelve months)

Enterprise value/sales is a valuation ratio that compares the company's enterprise value to its annual sales. It indicates the company's capacity to generate free cash flow. In general, the lower the ratio, the cheaper the company is.

EV/Sales is most often calculated as cash and cash equivalents subtracted from the sum of market capitalization and debt and divided by annual sales. Many analysts consider EV/sales to be a more accurate metric than Price/Sales as it considers both debt and equity holders in its calculation. One of the limitations of the calculation is that sales do not take into account a company's taxes or expenses.

EV/Sales a Health Care szektor a NASDAQ-on cégekben a Ayala Pharmaceuticals -hoz képest

Mit csinál Ayala Pharmaceuticals?

advaxis (nasdaq: adxs) is a late -stage biotechnology company developing multiple cancer immunotherapies based on its proprietary platform that redirects the immune system to kill cancer. the advaxis technology, using bioengineered live attenuated bacteria, listeria monocytogenes (lm), actively suppresses key components in the tumor microenvironment that contribute to the tumors growth and protection from immunologic attack.

ev/sales -hoz hasonló cégek Ayala Pharmaceuticals